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lettuce, strawberries, and broccoli for Salmonella, Shigella,
and  Escherichia coli O157:H7. To date, 95.4% of these
samples have been free of contamination. FDA has worked
closely with several countries (e.g., Costa Rica, Trinidad and
Tobago, Honduras, and Jamaica) to determine their needs
and capacities. Examples of training and outreach include a
Regional Outreach Meeting on Food Safety in Mexico City,
Mexico, and one in Santiago, Chile.
To paraphrase The Future of Public Health, the 1988
Institute on Medicine report, food safety is not just what
government regulators or industry quality assurance managers do.
Food safety is what society does to ensure the conditions under
which people can consume food that is safe, as well as wholesome
and nutritious. Safe food requires the work of producers and
consumers; industry and government; local, state, federal, and,
increasingly, international partners.
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Ethical issues in international research have received an
increasing amount of publicity over the past decade, as more
attention is focused on global health and expanded funding is
provided for research in the developing world. Much of the
discussion has focused on issues that arise when researchers
from countries rich in resources collaborate with researchers
from poorer countries. Some of the controversies result from
research on vaccines and drugs for emerging infectious
diseases. This panel addressed ongoing challenges to
conducting ethical research.
Christine Grady from the National Institutes of Health
reviewed existing international codes and guidelines for
conducting research. Ethical concerns in international
research often stem from the potential for study communities
in the developing world to be vulnerable to exploitation
because of their social and economic circumstances. Several
international codes provide guidance on the ethical conduct of
clinical research including the Declaration of Helsinki,
Council for International Organizations of Medical Sciences
(CIOMS), International Guidelines for Biomedical Research,
and the UNAIDS Guidance Document on Ethical Consider-
ations in HIV Vaccine Research. However, these codes are
recommendations, not legal imperatives. In addition, they do
not address how disagreements might be resolved. Dr. Grady
mentioned some current ethical dilemmas, including
determination of treatment provided to participants during
the course of a clinical trial, the obtaining of informed
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consent, obligations of researchers to the study community,
and investigators’ responsiveness to local health needs.
Although there are no easy answers, she suggested that basic
ethical principles should be applied globally, with local
interpretation and implementation.
Gita Ramjee from the South African Medical Research
Council discussed ethical problems and solutions used by South
African researchers conducting a phase-III trial of a vaginal
microbicide to prevent HIV infection. Researchers realized that
participants did not understand the details of the study.
Investigators then modified the process to include role playing
and to allow time for trial participants to consult with peers.
Researchers also added a knowledge testing component to the
trial. These changes suggest that informed consent is not a one-
time event but is instead an ongoing process.
The need to minimize the risk of participants’ contracting
HIV during the study necessitated an intensive counseling
component. Participants were informed about local HIV
counseling services, and sex workers were encouraged to set
standard prices and to refuse clients who would not use condoms.
This study shows how practical solutions can be used to reduce
risks associated with research.
Finally, Jean Pape from Les Centres GHESKIO in Port-au-
Prince, Haiti, highlighted the major challenges to conducting
international research, which center on obtaining ethical review
or institutional review board clearance.  See page 547 for a more
detailed article concerning this discussion.
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